Clinical Trial

Induce XT™ Bone Graft in Foot and Ankle Fusion

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate how effective Induce XT is in patients undergoing foot and/or ankle surgery. Induce XT is a bone graft material used in surgeries to fill gaps where bone is missing, such as during foot and ankle fusion. Participants in the study will have a screening visit to determine eligibility, followed by an assessment on the day of surgery and 5 follow-up visits over 12 months. These visits will include X-rays, pain evaluations, and questionnaires.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-24.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-11-17
Trial Details
NCT Number NCT06662266
Lead Sponsor Red Rock Regeneration Inc.
Conditions Surgery, Foot Deformities, Ankle Arthropathy
Enrollment 60 participants
Start Date 2025-05-12
Primary Completion 2026-11-01 (estimated)
Study Completion 2027-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-20